Published in Cancer Prev Res (Phila) on October 01, 2008
The human microbiome: at the interface of health and disease. Nat Rev Genet (2012) 7.54
What are the consequences of the disappearing human microbiota? Nat Rev Microbiol (2009) 5.62
Helicobacter pylori in health and disease. Gastroenterology (2009) 3.84
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest (2009) 3.26
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer (2009) 1.61
Microbiome and malignancy. Cell Host Microbe (2011) 1.45
Antibiotics, microbiota, and immune defense. Trends Immunol (2012) 1.33
Symptomatic reflux disease: the present, the past and the future. Gut (2014) 1.29
Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev (2011) 1.26
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer (2012) 1.19
Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007. Cancer Epidemiol Biomarkers Prev (2010) 1.19
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut (2011) 1.18
Gastric cancer: an infectious disease. Infect Dis Clin North Am (2010) 1.17
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut (2011) 1.14
The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol (2012) 1.13
Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila) (2008) 1.11
Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J Bacteriol (2010) 1.10
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PLoS One (2013) 1.08
Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res (2015) 1.06
Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. Br J Cancer (2009) 1.05
Role of bacteria in oncogenesis. Clin Microbiol Rev (2010) 1.05
Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology (2010) 1.03
Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer (2011) 1.00
Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol (2014) 0.96
Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci (2012) 0.96
Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer (2014) 0.92
Epidemiologic studies of the human microbiome and cancer. Br J Cancer (2016) 0.91
The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev (2011) 0.91
Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. Evol Appl (2014) 0.91
The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst (2011) 0.91
Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J Gastroenterol (2013) 0.91
The association between obesity factor and esophageal caner. J Gastrointest Oncol (2012) 0.90
Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids (2011) 0.90
Current status and future perspectives on the etiology of esophageal adenocarcinoma. Front Oncol (2012) 0.89
Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev Cancer (2016) 0.87
Upper gastrointestinal cancer and reflux disease. J Gastric Cancer (2013) 0.86
Iron intake and markers of iron status and risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Causes Control (2010) 0.85
Helicobacter pylori seropositivity and risk of lung cancer. PLoS One (2012) 0.85
Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci (2012) 0.85
Ethnicity in relation to incidence of oesophageal and gastric cancer in England. Br J Cancer (2012) 0.84
Equilibria of humans and our indigenous microbiota affecting asthma. Proc Am Thorac Soc (2012) 0.84
Barrett's esophagus and cancer risk: how research advances can impact clinical practice. Gut Liver (2014) 0.82
Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut (2011) 0.82
Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort. Cancer Epidemiol Biomarkers Prev (2014) 0.82
Barrett's Esophagus in an Area with an Exceptionally Low Prevalence of Helicobacter pylori Infection. ISRN Gastroenterol (2011) 0.81
Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling. Oncotarget (2016) 0.80
Positive selection on a bacterial oncoprotein associated with gastric cancer. Gut Pathog (2011) 0.80
Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods. PLoS One (2014) 0.80
Diverging trends in the incidence of reflux-related and Helicobacter pylori-related gastric cardia cancer. J Clin Gastroenterol (2013) 0.80
A Systematic Review and Meta-Analysis Study to Investigate the Prevalence of Helicobacter pylori and the Sensitivity of its Diagnostic Methods in Iran. Iran Red Crescent Med J (2014) 0.79
Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers. Cancer Med (2016) 0.79
Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am (2015) 0.79
Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status. Carcinogenesis (2014) 0.79
Does the risk of stomach cancer remain among second-generation immigrants in Sweden? Gastric Cancer (2011) 0.78
Microbiome, innate immunity, and esophageal adenocarcinoma. Clin Lab Med (2014) 0.78
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas. BMC Cancer (2015) 0.78
Association of dietary fat intakes with risk of esophageal and gastric cancer in the NIH-AARP diet and health study. Int J Cancer (2012) 0.78
At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol (2014) 0.78
Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J (2015) 0.78
Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol (2015) 0.77
The role of Helicobacter pylori in the spectrum of Barrett's carcinogenesis. Cancer Prev Res (Phila) (2009) 0.77
Human microbiome and cancer: an insight. Indian J Microbiol (2012) 0.77
Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci (2016) 0.77
Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment. Glob Adv Health Med (2014) 0.77
The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer. Cell Mol Gastroenterol Hepatol (2016) 0.76
The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease. Dig Dis Sci (2013) 0.76
Gastric cardia cancer: how much is it from fat? Dig Dis Sci (2012) 0.76
An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. Dis Esophagus (2016) 0.76
Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence. World J Gastrointest Endosc (2015) 0.75
The epidemiology, diagnosis, and treatment of Barrett's carcinoma. Dtsch Arztebl Int (2015) 0.75
Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma. Clinics (Sao Paulo) (2017) 0.75
The intestinal microbiome and surgical disease. Curr Probl Surg (2016) 0.75
Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors. Middle East J Dig Dis (2016) 0.75
Grand challenges in cancer epidemiology and prevention. Front Oncol (2011) 0.75
The Relationship between Eating and Lifestyle Habits and Cancer in Van Lake Region: Another Endemic Region for Esophageal and Gastric Cancers. J Cancer Epidemiol (2015) 0.75
Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers. Am J Clin Nutr (2016) 0.75
The hallmarks of premalignant conditions: a molecular basis for cancer prevention. Semin Oncol (2015) 0.75
Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity. Front Microbiol (2017) 0.75
Fatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice. J Gastroenterol (2016) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Helicobacter pylori infection. N Engl J Med (2002) 14.81
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13
Spurious precision? Meta-analysis of observational studies. BMJ (1998) 5.45
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut (2001) 4.97
Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69
Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology (2003) 4.52
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2002) 4.43
The cohort effect and Helicobacter pylori. J Infect Dis (1993) 4.28
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis (2008) 3.95
Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer (2004) 3.88
Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med (2007) 3.48
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
Does Helicobacter pylori protect against asthma and allergy? Gut (2008) 2.67
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63
Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest (2001) 2.58
Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol (2001) 2.56
Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep (2006) 2.54
Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis (2000) 2.52
Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer (2004) 2.46
Meta-analysis/Shmeta-analysis. Am J Epidemiol (1994) 2.43
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol (2007) 2.31
Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis (2005) 2.28
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut (2007) 2.28
Gut hormones and appetite control. Gastroenterology (2007) 2.16
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer (2006) 1.64
Responses of endoscopy patients in Ladakh, India, to Helicobacter pylori whole-cell and Cag A antigens. Clin Diagn Lab Immunol (2002) 1.55
Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer (2003) 1.55
Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut (2007) 1.52
Association between Helicobacter pylori infection and pancreatic cancer. Oncology (1998) 1.49
Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol (2007) 1.49
The prevalence of Campylobacter pylori in gastric biopsies from cancer patients. Mod Pathol (1989) 1.48
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. Cancer (2000) 1.39
Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer (2002) 1.37
Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol (2000) 1.28
Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer (2006) 1.18
Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol (2001) 1.17
Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev (2002) 1.14
Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev (2005) 1.14
Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer (1999) 1.13
An endangered species in the stomach. Sci Am (2005) 1.11
Meta-analysis: Can we mix apples and oranges? Am J Gastroenterol (2004) 1.11
Gastric cancer and H pylori. Gut (2002) 1.09
Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia. Am J Gastroenterol (2002) 1.05
Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol (2007) 1.05
Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol (2007) 1.04
Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter (2001) 1.03
Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Aust N Z J Surg (2000) 1.03
Fiber intake and risk of adenocarcinomas of the esophagus and stomach. Cancer Causes Control (2007) 1.01
Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol (2005) 0.98
Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors. World J Gastroenterol (2003) 0.96
Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus. Am J Surg Pathol (1997) 0.93
Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia? Digestion (2000) 0.91
Barrett's esophagus and the presence of Helicobacter pylori. Am J Gastroenterol (1998) 0.91
Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg (1999) 0.91
Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer (2007) 0.90
Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol (1999) 0.90
Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Dis Esophagus (1997) 0.86
Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer (2008) 0.85
Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol (2007) 0.84
Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus. Hum Pathol (1997) 0.84
Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer (2003) 0.81
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43
Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol (2009) 2.10
Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol (2013) 2.07
Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (2012) 2.07
The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01
Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev (2004) 1.95
Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens (2013) 1.86
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health (2006) 1.75
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut (2010) 1.71
High-temperature beverages and foods and esophageal cancer risk--a systematic review. Int J Cancer (2009) 1.61
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60
Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett (2005) 1.53
Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers. Scand J Gastroenterol (2005) 1.48
Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.47
Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS One (2010) 1.47
Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol (2004) 1.47
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology (2011) 1.44
Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg (2005) 1.39
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol (2012) 1.30
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol (2005) 1.21
Diabetes mellitus and its correlates in an Iranian adult population. PLoS One (2011) 1.19
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut (2011) 1.18
Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer (2008) 1.11
Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking maté in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer (2006) 1.10
Fruits, vegetables, and antioxidants and risk of gastric cancer among male smokers. Cancer Epidemiol Biomarkers Prev (2005) 1.08
Patterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer. Nutr Cancer (2009) 1.07
Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer (2013) 1.06
No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer (2010) 1.06
How can primary health care system and community-based participatory research be complementary? Int J Prev Med (2010) 1.05
Reducing the burden of chronic diseases: a neglected agenda in Iranian health care system, requiring a plan for action. Arch Iran Med (2010) 1.04
Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol (2003) 1.02
Pneumatosis and portal venous gas: do CT findings reassure? J Surg Res (2013) 1.00
Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett (2004) 1.00
Pickled food and risk of gastric cancer--a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev (2012) 0.98
Poor oral health as a risk factor for esophageal squamous dysplasia in northeastern Iran. Anticancer Res (2005) 0.98
Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One (2011) 0.97
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev (2006) 0.95
The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol (2012) 0.95
Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res (2009) 0.94
Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res (Phila) (2013) 0.92
The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst (2011) 0.91
MKK4 status predicts survival after resection of gastric adenocarcinoma. Arch Surg (2006) 0.90
Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart (2012) 0.89
The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil. Carcinogenesis (2006) 0.88
Iron in relation to gastric cancer in the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev (2012) 0.87
Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, Iran. PLoS One (2011) 0.87
Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China. J Natl Cancer Inst (2007) 0.87
Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PLoS One (2012) 0.86
Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study. BMC Med (2015) 0.86
The gastric cardia is not a target for human papillomavirus-induced carcinogenesis. Cancer Epidemiol Biomarkers Prev (2010) 0.85
Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci (2012) 0.85
Cooking methods and esophageal squamous cell carcinoma in high-risk areas of Iran. Nutr Cancer (2013) 0.84
Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol (2014) 0.84
Use of proton pump inhibitors and risk of progression of Barrett's esophagus to neoplastic lesions. Am J Gastroenterol (2009) 0.84
Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cells. Bioorg Med Chem (2011) 0.84
Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: a case-control study in a high-risk area and literature review. Eur J Cancer Prev (2013) 0.83
Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control (2009) 0.83
Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: a 7-year cross-sectional study. PLoS One (2012) 0.82
Predicting gangrenous cholecystitis. HPB (Oxford) (2014) 0.82
Vitamin E intake and risk of esophageal and gastric cancers in the NIH-AARP Diet and Health Study. Int J Cancer (2009) 0.82
Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut (2011) 0.82
Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer (2006) 0.81
Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. Am J Gastroenterol (2005) 0.80
Esophageal cancer incidence trends in northeastern Iran: comparing rates over 36 years. Arch Iran Med (2012) 0.80
Re: Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2003) 0.79
Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis. Medicine (Baltimore) (2016) 0.78
Contact with ruminants is associated with esophageal squamous cell carcinoma risk. Int J Cancer (2014) 0.78
Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study. Cancer Epidemiol (2009) 0.78
A U-shaped relationship between haematocrit and mortality in a large prospective cohort study. Int J Epidemiol (2013) 0.78
Polycyclic aromatic hydrocarbons: determinants of urinary 1-hydroxypyrene glucuronide concentration and risk of colorectal cancer in the Shanghai Women's Health Study. BMC Cancer (2013) 0.78
Food preparation methods, drinking water source, and esophageal squamous cell carcinoma in the high-risk area of Golestan, Northeast Iran. Eur J Cancer Prev (2016) 0.78
Significant variation in the concentration of carcinogenic polycyclic aromatic hydrocarbons in yerba maté samples by brand, batch, and processing method. Environ Sci Technol (2012) 0.77
Variation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotype. Int J Cancer (2012) 0.76
Effectiveness and feasibility of lifestyle and low-cost pharmacologic interventions in the prevention of chronic diseases: a review. Arch Iran Med (2011) 0.76
Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Medicine (Baltimore) (2016) 0.75
Grand challenges in cancer epidemiology and prevention. Front Oncol (2011) 0.75
SILC: significantly inferior laparoscopic cholecystectomy? J Am Coll Surg (2013) 0.75
Updated literature on povidone-iodine for control of surgical site infections. Ann Surg (2012) 0.75
Inflammatory breast cancer: yet another risk of the obesity epidemic? J Natl Cancer Inst (2013) 0.75
Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The Golestan Cohort Study. Am J Epidemiol (2017) 0.75
Prophylactic Octreotide for Pancreatectomy: Benefit or Harm? Correspondence re McMillan et al, 2016;264: 344. Ann Surg (2017) 0.75
Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation. Leuk Lymphoma (2015) 0.75